Shares outstanding · 2011–2025
Iovance Biotherapeutics shares outstanding
412M+35.0% · FY2025
Iovance Biotherapeutics (IOVA) reported 412M in shares outstanding for fiscal 2025, +35.0% year on year.
| Fiscal year | Shares outstanding | Change | Filing |
|---|---|---|---|
| FY20252026-02-13 | 412M | +35.0% | Open → |
| FY20242024-12-31 | 305M | +19.2% | Open → |
| FY20232023-12-31 | 256M | +36.4% | Open → |
| FY20222022-12-31 | 188M | +19.6% | Open → |
| FY20212021-12-31 | 157M | +6.2% | Open → |
| FY20202020-12-31 | 148M | +17.0% | Open → |
| FY20192019-12-31 | 126M | +2.4% | Open → |
| FY20182019-02-13 | 123M | +68.7% | Open → |
| FY20172017-12-31 | 73.2M | +17.5% | Open → |
| FY20162016-12-31 | 62.2M | +28.2% | Open → |
| FY20152015-12-31 | 48.5M | +43.8% | Open → |
| FY20142014-12-31 | 33.8M | +68.5% | Open → |
| FY20132013-12-31 | 20.0M | −74.4% | Open → |
| FY20122013-01-18 | 78.3M | +6.3% | Open → |
| FY20112011-11-18 | 73.6M | — | Open → |
Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +13.1%
Shares outstanding at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Iovance Biotherapeutics shares outstanding |url=https://companiesranked.com/en/company/iovance-biotherapeutics/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Iovance Biotherapeutics shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/iovance-biotherapeutics/shares-outstandingBibTeX
@misc{companiesranked-en-company-iovance-biotherapeutics-shares-outstanding-2026,
author = {{CompaniesRanked}},
title = {{Iovance Biotherapeutics shares outstanding}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/iovance-biotherapeutics/shares-outstanding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001104659-26-018899 · February 24, 2026
{{cite web |title=Iovance Biotherapeutics shares outstanding — 10-K (0001104659-26-018899) |url=https://www.sec.gov/Archives/edgar/data/1425205/000110465926018899/iova-20251231x10k.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.